Daniel A. BriereSenior Director, Cardiometabolic Research at Eli Lilly and CompanySpeaker
Agenda Sessions
Cycle Time Is a Quality Metric: Eloralintide from Discovery to Clinical Proof of Concept
, 16:00View Session

